PT  - JOURNAL ARTICLE
AU  - Carlos Antonio  Moura
AU  - Carlos Geraldo  Moura
AU  - Ana Luísa  Cerqueira De Sant’ana Costa
TI  - SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets — What to Learn from Rheumatologists
AID  - 10.3899/jrheum.200657
DP  - 2020 May 25
TA  - The Journal of Rheumatology
PG  - jrheum.200657
4099  - http://www.jrheum.org/content/early/2020/07/09/jrheum.200657.short
4100  - http://www.jrheum.org/content/early/2020/07/09/jrheum.200657.full
AB  - It was with great interest that we read the editorial by Drs. Cron and Chatham1 linking the cytokine storm syndrome (CSS) seen in macrophage activation syndrome, common in the rheumatological setting, with a CSS postulated to be a background in the novel coronavirus (SARS-CoV-2) infection. Amid the high contagion of the virus, science was also infected by an infodemic, compelled to finish the race to find effective therapies, while physicians managed real-world patients.